Type
Hormone Testing
Biomarkers
6
Duration
10 min
A six-biomarker panel investigating the hormonal and nutritional factors most commonly associated with hair thinning and hair loss in women. The panel covers iron stores, thyroid function, and androgenic markers including free androgen index, SHBG, and testosterone alongside a complete blood count.
Hair loss in women is frequently multifactorial, and identifying the contributing factors requires looking beyond the scalp to the underlying hormonal and nutritional environment. This panel targets the six markers most commonly implicated in female hair thinning: ferritin (iron stores), TSH (thyroid function), and a set of androgenic hormones that influence hair follicle cycling. Ferritin is often the most overlooked factor — iron deficiency is one of the most common reversible causes of diffuse hair loss in premenopausal women, and levels can be suboptimal long before full anaemia develops. TSH screens for thyroid dysfunction, which directly affects hair growth cycles. The androgenic markers — testosterone, SHBG, and free androgen index (FAI) — assess whether elevated androgen activity may be contributing to thinning, particularly at the crown and temples. The complete blood count adds haematological context, helping to identify anaemia or other blood cell abnormalities that may be relevant. This panel is designed as a first-line investigation for women noticing increased shedding, visible thinning, or changes in hair texture. Results from this panel often guide decisions about supplementation, further hormonal investigation, or referral to a dermatologist or endocrinologist for targeted treatment.
Key Details
- Biomarkers
- 6
- Focus
- Female hair loss investigation
- Duration
- ~10 min
- Accreditation
- DAkkS / ISO 15189
Who Is This For?
Women experiencing hair thinning, increased shedding, or changes in hair texture seeking a targeted diagnostic panel
